Cargando…
Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report
Hereditary breast and ovarian cancer (HBOC) syndrome has increased predisposition to breast and/or ovarian cancer, and 24% of families with HBOC were associated with the germline pathogenic variants in BRCA1/2. Timely diagnosis and identification of mutation carriers is of utmost importance to impro...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719216/ https://www.ncbi.nlm.nih.gov/pubmed/36463302 http://dx.doi.org/10.1186/s13048-022-01069-y |
_version_ | 1784843271984381952 |
---|---|
author | Liu, Ying Zhu, Jing Wei, Xiao Yang, Duoxia Li, Si Qian, Xiaoping Li, Li |
author_facet | Liu, Ying Zhu, Jing Wei, Xiao Yang, Duoxia Li, Si Qian, Xiaoping Li, Li |
author_sort | Liu, Ying |
collection | PubMed |
description | Hereditary breast and ovarian cancer (HBOC) syndrome has increased predisposition to breast and/or ovarian cancer, and 24% of families with HBOC were associated with the germline pathogenic variants in BRCA1/2. Timely diagnosis and identification of mutation carriers is of utmost importance to improve survival benefit and quality of life. Cancers that have been included into screening of BRCA1/2 associated HBOC included prostate and pancreatic cancers etc. In this case, we reported a patient who firstly presented symptoms of CRC and was finally diagnosed as BRCA1 associated HBOC with advanced peritoneal carcinoma. With strategies of cetuximab based treatment and olaparib, and debulking surgeries, she has achieved an overall survival (OS) > 35 months. The aim was to indicate that HBOC might also first present as CRC, and comprehensive next-generation sequencing analysis might be a key complement for screening and diagnose of HBOC. |
format | Online Article Text |
id | pubmed-9719216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97192162022-12-04 Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report Liu, Ying Zhu, Jing Wei, Xiao Yang, Duoxia Li, Si Qian, Xiaoping Li, Li J Ovarian Res Case Report Hereditary breast and ovarian cancer (HBOC) syndrome has increased predisposition to breast and/or ovarian cancer, and 24% of families with HBOC were associated with the germline pathogenic variants in BRCA1/2. Timely diagnosis and identification of mutation carriers is of utmost importance to improve survival benefit and quality of life. Cancers that have been included into screening of BRCA1/2 associated HBOC included prostate and pancreatic cancers etc. In this case, we reported a patient who firstly presented symptoms of CRC and was finally diagnosed as BRCA1 associated HBOC with advanced peritoneal carcinoma. With strategies of cetuximab based treatment and olaparib, and debulking surgeries, she has achieved an overall survival (OS) > 35 months. The aim was to indicate that HBOC might also first present as CRC, and comprehensive next-generation sequencing analysis might be a key complement for screening and diagnose of HBOC. BioMed Central 2022-12-03 /pmc/articles/PMC9719216/ /pubmed/36463302 http://dx.doi.org/10.1186/s13048-022-01069-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Liu, Ying Zhu, Jing Wei, Xiao Yang, Duoxia Li, Si Qian, Xiaoping Li, Li Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report |
title | Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report |
title_full | Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report |
title_fullStr | Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report |
title_full_unstemmed | Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report |
title_short | Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report |
title_sort | metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with germline brca1 mutation: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719216/ https://www.ncbi.nlm.nih.gov/pubmed/36463302 http://dx.doi.org/10.1186/s13048-022-01069-y |
work_keys_str_mv | AT liuying metastaticcolorectalcancerastheprimaryphenotypeinahereditarybreastandovariancancerpatientwithgermlinebrca1mutationacasereport AT zhujing metastaticcolorectalcancerastheprimaryphenotypeinahereditarybreastandovariancancerpatientwithgermlinebrca1mutationacasereport AT weixiao metastaticcolorectalcancerastheprimaryphenotypeinahereditarybreastandovariancancerpatientwithgermlinebrca1mutationacasereport AT yangduoxia metastaticcolorectalcancerastheprimaryphenotypeinahereditarybreastandovariancancerpatientwithgermlinebrca1mutationacasereport AT lisi metastaticcolorectalcancerastheprimaryphenotypeinahereditarybreastandovariancancerpatientwithgermlinebrca1mutationacasereport AT qianxiaoping metastaticcolorectalcancerastheprimaryphenotypeinahereditarybreastandovariancancerpatientwithgermlinebrca1mutationacasereport AT lili metastaticcolorectalcancerastheprimaryphenotypeinahereditarybreastandovariancancerpatientwithgermlinebrca1mutationacasereport |